Itovebi (inavolisib)

$12,352.50

PI3K inhibitor for breast cancer

SKU: itovebi-inavolisib Category: Tags: , , ,

Description

Itovebi (inavolisib) is a PI3K alpha-selective inhibitor for PIK3CA-mutated hormone receptor-positive breast cancer.

Reviews

There are no reviews yet.

Be the first to review “Itovebi (inavolisib)”

Your email address will not be published. Required fields are marked *